Tislelizumab Plus Cisplatin/Carboplatin And Gemcitabine Versus Placebo Plus Cisplatin/Carboplatin And Gemcitabine In Chinese Patients With Advanced Urothelial Carcinoma: A Phase Iii Trial In Progress

Feng Bi,Han-Zhong Li,Shaoxing Zhu,Qing Zou, Jia Tang, Wei Zhang,Dingwei Ye

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览49

暂无评分

摘要

TPS588Background: Platinum-based chemotherapy is standard first-line treatment for patients with advanced urothelial carcinoma (UC). Checkpoint inhibitors (ie, anti-PD-1 antibodies) are first-line ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要